Means Investment Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
3,273
+6
| +0.2% | +$479 | 0.02% | 172 |
|
|
2025
Q1 | $283K | Sell |
3,267
-67
| -2% | -$5.8K | 0.03% | 162 |
|
|
2024
Q4 | $275K | Buy |
3,334
+6
| +0.2% | +$496 | 0.03% | 175 |
|
|
2024
Q3 | $289K | Buy |
3,328
+4
| +0.1% | +$348 | 0.03% | 169 |
|
|
2024
Q2 | $273K | Buy |
3,324
+5
| +0.2% | +$411 | 0.03% | 163 |
|
|
2024
Q1 | $266K | Sell |
3,319
-750
| -18% | -$60.1K | 0.03% | 172 |
|
|
2023
Q4 | $310K | Sell |
4,069
-299
| -7% | -$22.8K | 0.04% | 157 |
|
|
2023
Q3 | $316K | Sell |
4,368
-612
| -12% | -$44.3K | 0.05% | 155 |
|
|
2023
Q2 | $377K | Buy |
4,980
+7
| +0.1% | +$529 | 0.06% | 140 |
|
|
2023
Q1 | $378K | Sell |
4,973
-93
| -2% | -$7.07K | 0.07% | 138 |
|
|
2022
Q4 | $398K | Buy |
5,066
+7
| +0.1% | +$550 | 0.08% | 132 |
|
|
2022
Q3 | $361K | Buy |
5,059
+7
| +0.1% | +$500 | 0.08% | 136 |
|
|
2022
Q2 | $379K | Buy |
5,052
+9
| +0.2% | +$675 | 0.08% | 131 |
|
|
2022
Q1 | $401K | Buy |
5,043
+8
| +0.2% | +$636 | 0.07% | 130 |
|
|
2021
Q4 | $408K | Buy |
5,035
+7
| +0.1% | +$567 | 0.07% | 130 |
|
|
2021
Q3 | $389K | Buy |
5,028
+255
| +5% | +$19.7K | 0.08% | 132 |
|
|
2021
Q2 | $384K | Buy |
4,773
+5
| +0.1% | +$402 | 0.08% | 137 |
|
|
2021
Q1 | $376K | Buy |
4,768
+6
| +0.1% | +$473 | 0.09% | 127 |
|
|
2020
Q4 | $386K | Buy |
4,762
+5
| +0.1% | +$405 | 0.09% | 121 |
|
|
2020
Q3 | $309K | Sell |
4,757
-119
| -2% | -$7.73K | 0.08% | 112 |
|
|
2020
Q2 | $319K | Buy |
4,876
+7
| +0.1% | +$458 | 0.1% | 106 |
|
|
2020
Q1 | $293K | Buy |
4,869
+7
| +0.1% | +$421 | 0.11% | 99 |
|
|
2019
Q4 | $322K | Sell |
4,862
-437
| -8% | -$28.9K | 0.11% | 113 |
|
|
2019
Q3 | $320K | Buy |
5,299
+7
| +0.1% | +$423 | 0.12% | 113 |
|
|
2019
Q2 | $318K | Sell |
5,292
-493
| -9% | -$29.6K | 0.13% | 112 |
|
|
2019
Q1 | $377K | Sell |
5,785
-455
| -7% | -$29.7K | 0.17% | 98 |
|
|
2018
Q4 | $389K | Buy |
+6,240
| New | +$389K | 0.22% | 81 |
|